0001085146-13-000911.txt : 20130513
0001085146-13-000911.hdr.sgml : 20130513
20130513164931
ACCESSION NUMBER: 0001085146-13-000911
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130331
FILED AS OF DATE: 20130513
DATE AS OF CHANGE: 20130513
EFFECTIVENESS DATE: 20130513
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Consonance Capital Management LP
CENTRAL INDEX KEY: 0001544773
IRS NUMBER: 260294313
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-14924
FILM NUMBER: 13838005
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 43RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212.660-8062
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 43RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
13F-HR
1
consanance1q2013.txt
CONSONANCE CAPITAL MANAGEMENT LP
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: March 31, 2013
Check here if Amendment [ ]; Amendment Number:
This Amendment (Check only one.): [ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Consonance Capital Management LP
Address: 888 Seventh Avenue, 43rd Floor
New York, NY 10019
13F File Number: 028-14924
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Wendell Fowler
Title: Chief Financial Officer
Phone: 212-660-8077
Signature, Place, and Date of Signing:
/s/ Wendell Fowler New York, NY May 13, 2013
Report Type (Check only one.):
[ X] 13F HOLDINGS REPORT.
[ ] 13F NOTICE.
[ ] 13F COMBINATION REPORT.
FORM 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 19
Form 13F Information Table Value Total: $215,630 (thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional managers with respect to which this report is filed, other
than the manager filing this report.
NONE
FORM 13F INFORMATION TABLE
VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE
------------------------------ ---------------- --------- -------- -------- --- ---- ------- ------------ -------- -------- --------
AFFYMETRIX INC COM 00826T108 18607 3942226 SH SOLE 3942226 0 0
AMAG PHARMACEUTICALS INC COM 00163U106 12666 531086 SH SOLE 531086 0 0
AMARIN CORP PLC SPONS ADR NEW 023111206 4527 610900 SH SOLE 610900 0 0
BIOSCRIP INC COM 09069N108 5562 437634 SH SOLE 437634 0 0
CHINDEX INTERNATIONAL INC COM 169467107 3185 231792 SH SOLE 231792 0 0
DEPOMED INC COM 249908104 5280 899405 SH SOLE 899405 0 0
DYAX CORP COM 26746E103 742 170100 SH SOLE 170100 0 0
EXPRESS SCRIPTS HLDG CO COM 30219G108 12371 214700 SH SOLE 214700 0 0
FURIEX PHARMACEUTICALS INC COM 36106P101 21441 572075 SH SOLE 572075 0 0
GLOBUS MED INC CL A 379577208 13157 896245 SH SOLE 896245 0 0
JAZZ PHARMACEUTICALS PLC SHS USD G50871105 18987 339600 SH SOLE 339600 0 0
LIPOSCIENCE INC COM 53630M108 4375 416313 SH SOLE 416313 0 0
MEDICINES CO COM 584688105 21432 641498 SH SOLE 641498 0 0
NANOSPHERE INC COM 63009F105 2090 954184 SH SOLE 954184 0 0
NPS PHARMACEUTICALS INC COM 62936P103 17271 1692398 SH SOLE 1692398 0 0
QUESTCOR PHARMACEUTICALS INC COM 74835Y101 7159 220000 SH SOLE 220000 0 0
SALIX PHARMACEUTICALS INC COM 795435106 26596 519662 SH SOLE 519662 0 0
TARO PHARMACEUTICAL INDS LTD SHS M8737E108 3366 57356 SH SOLE 57356 0 0
UNITED THERAPEUTICS CORP DEL COM 91307C102 16816 276266 SH SOLE 276266 0 0